Brief: Codex DNA Reports Q3 2021 Financial Results
09/11/2021 22:39
Nov 9 (Reuters) - Codex DNA Inc DNAY.O :
* CODEX DNA REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.34
* Q3 REVENUE ROSE 70 PERCENT TO $2.8 MILLION
Source text for Eikon: ID:nGNX49Xqkm
Further company coverage: DNAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview